Login to Your Account

Market reshuffling: China’s revised NRDL to boost pharma sector

By Carmen Ho
Staff Writer

Friday, February 24, 2017

HONG KONG – China has added more than 300 new drugs to the National Reimbursement Drug List in its latest revision released Friday – the first since 2009.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription